# Freya Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/freya-biosciences

- Industry: Biotechnology
- Headquarters: Copenhagen, Denmark
- Website: www.freyabiosciences.com
- Total disclosed funding: $50M
- Latest round: Series A (Sep 30, 2024)
- Investors on record: 8

## About

Based in Copenhagen, Denmark, and founded in 2023 by its CEO Colleen Acosta, CSO Johan van Hylckama Vlieg, and CBO Ulrich Binné, Freya Biosciences operates as a clinical-stage company operates as a provider of biotechnology for the treatment of infertility in women with dysbiotic vaginal microbiota. In December 2023, Freya Biosciences raised USD 38 million in series A funding co-led by Sofinnova Partners and OMX Ventures, with participation from Export and Investment Fund of Denmark, Angelini Ventures, CE-Ventures, Corundum Systems Biology, and Indaco Venture Partners. An individual investors also participated in the round. 

Freya Biosciences offers a data science platform that employs quantitative and whole-genome sequencing, proteomic and transcriptomic immune markers, along with clinical outcomes and demographic data to develop therapeutic solutions. The company's focus areas include IVF and natural conception, endometriosis-related infertility, preterm birth, and various other women's health conditions linked to local immune dysregulation.

The company plans to use the Series A funding to develop an immunotherapy platform that specifically targets the vaginal microbiota.

## Funding rounds

- Series A, Sep 30, 2024, $12M — Sofinnova Partners, Gates Foundation Trust, OMX Ventures, Export and Investment Fund of Denmark
- Series A, Dec 12, 2023, $38M — Sofinnova Partners, Crescent Enterprises Venture Capital, Indaco Venture Partners, OMX Ventures, Corundum Systems Biology, Angelini Ventures, Export and Investment Fund of Denmark

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A
- Crescent Enterprises Venture Capital (https://capitalatlas.ai/funds/crescent-enterprises-venture-capital) — Series A
- Indaco Venture Partners (https://capitalatlas.ai/funds/indaco-venture-partners) — Series A
- OMX Ventures (https://capitalatlas.ai/funds/omx-ventures) — Series A
- Corundum Systems Biology (https://capitalatlas.ai/funds/corundum-systems-biology) — Series A
- Angelini Ventures (https://capitalatlas.ai/funds/angelini-ventures) — Series A
- Export and Investment Fund of Denmark (https://capitalatlas.ai/funds/export-and-investment-fund-of-denmark) — Series A
- Gates Foundation Trust — Series A